A Early Study of ABSK131 in Patients With Advanced/Metastatic Solid Tumors

NCT07288957 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

266

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumors (Phase 1)

Interventions

DRUG: ABSK131

Sponsor

Abbisko Therapeutics Co, Ltd